Summary
- Current Price
- As of today, EBS price is $8.23, down -1.79% on
- Current Price All-Time High
- EBS price is currently -94.02% below its historical high of $137.61 set on
- Market Cap
- EBS current market cap is $439M, up +55.83% over the past 365 days
- PE Ratio
- EBS current PE ratio is 9.92
- Revenue
- EBS current annual revenue is $742.90M, down -28.81% year-over-year
- Next Earnings
- The next earnings release for EBS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Emergent BioSolutions Inc. |
| Ticker | NYSE: EBS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | emergentbiosolutions.com |
| Employees | 900 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $8.23 | |
| Price, 1D Change | -1.79% | |
| $439M | ||
| - | ||
| 9.92 | ||
| 1.44 | ||
| $743M | ||
| Revenue, 1Y Change | -28.81% | |
| $0.93 | ||
| EPS, 1Y Change | +125.80% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.93 | ||
| EPS Estimate | N/A | $0.52 |
| EPS Est. Change | N/A | -43.95% |
| $742.90M | ||
| Revenue Estimate | N/A | $745.00M |
| Revenue Est. Change | N/A | +0.28% |
| Current Price | $8.23 | |
| Price Target | - | $12.00 |
| Price Tgt. Change | - | +45.81% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.81 | -$3.60 | -342.28% | |
| $2.05 | $0.93 | -54.75% | |
| $0.52 | N/A | -43.95% | |
| $0.23 | N/A | -75.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.10B | $1.04B | -5.44% | |
| $809.40M | $742.90M | -8.22% | |
| $745.00M | N/A | +0.28% | |
| $892.00M | N/A | +20.07% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $8.23 | |
| $9.45 | ||
| SMA 200 vs Price | +14.84% | |
| $9.76 | ||
| SMA 50 vs Price | +18.60% | |
| 1.44 | ||
| $0.40 | ||
| 40.93 | ||
| 30.35% | ||
| 93.10% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $742.90M | ||
| $0.93 | ||
| $350.60M | ||
| 47.19% | ||
| $110.20M | ||
| 14.83% | ||
| $52.60M | ||
| 7.08% | ||
| $208.50M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.12 | ||
| 5.01 | ||
| 2.41 | ||
| - | ||
| 8 | ||
| 1.19 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 9.92 | ||
| 0.59 | ||
| 0.84 | ||
| 3.94 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $522.60M | ||
| $209.10M | ||
| $1.33B | ||
| $662.50M | ||
| $809.40M | ||
| $132.20M | ||
| $583.70M | ||
| $2.40M | ||
| $55.60M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $690.30M | ||
| $240.40M | ||
| $392.30M | ||
| $186.10M | ||
| $95.80M | ||
| $0.00 | ||
| $30.20M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $170.60M | ||
| $69.40M | ||
| -$136.60M | ||
| $13.80M | ||
| $156.80M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Benchmark | → |
Analyst sentiment
Institutional ownership
Screeners with EBS
FAQ
What is the ticker symbol for Emergent BioSolutions Inc.?
The ticker symbol for Emergent BioSolutions Inc. is NYSE:EBS
Does Emergent BioSolutions Inc. pay dividends?
No, Emergent BioSolutions Inc. does not pay dividends
What sector is Emergent BioSolutions Inc. in?
Emergent BioSolutions Inc. is in the Healthcare sector
What industry is Emergent BioSolutions Inc. in?
Emergent BioSolutions Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Emergent BioSolutions Inc. based in?
Emergent BioSolutions Inc. is headquartered in United States
When did Emergent BioSolutions Inc. go public?
Emergent BioSolutions Inc. initial public offering (IPO) was on November 15, 2006
Is Emergent BioSolutions Inc. in the S&P 500?
No, Emergent BioSolutions Inc. is not included in the S&P 500 index
Is Emergent BioSolutions Inc. in the NASDAQ 100?
No, Emergent BioSolutions Inc. is not included in the NASDAQ 100 index
Is Emergent BioSolutions Inc. in the Dow Jones?
No, Emergent BioSolutions Inc. is not included in the Dow Jones index
When was Emergent BioSolutions Inc. last earnings report?
Emergent BioSolutions Inc.'s most recent earnings report was on February 26, 2026
When does Emergent BioSolutions Inc. report earnings?
The next expected earnings date for Emergent BioSolutions Inc. is May 6, 2026
Data Sources & References
- EBS Official Website www.emergentbiosolutions.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1367644/000136764426000015/0001367644-26-000015-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1367644/000136764426000015/0001367644-26-000015-index.htm
- EBS Profile on Yahoo Finance finance.yahoo.com/quote/EBS
- EBS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ebs